110 related articles for article (PubMed ID: 3162652)
1. Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections.
Poindexter AN; Ritter M; Faro S; Castellano MA; Gentry LO; Ismail M; Knuppel RA; Kreutner AK; Lamb EJ; LeFrock JL
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):717-21. PubMed ID: 3162652
[TBL] [Abstract][Full Text] [Related]
2. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
[TBL] [Abstract][Full Text] [Related]
3. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
Knuppel RA; O'Bryan D; Lake M
South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
[TBL] [Abstract][Full Text] [Related]
5. Role of cephamycins in obstetrics and gynecology.
Sweet RL
J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
[TBL] [Abstract][Full Text] [Related]
6. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W
Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970
[TBL] [Abstract][Full Text] [Related]
7. Cefotetan in the treatment of obstetric and gynecologic infections.
Poindexter AN; Sweet R; Ritter M
Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
[TBL] [Abstract][Full Text] [Related]
8. Results of a single-center study of cefotetan prophylaxis in abdominal or vaginal hysterectomy.
Gordon SF
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):710-4. PubMed ID: 3128113
[TBL] [Abstract][Full Text] [Related]
9. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.
Geckler RW; Eng RH; Fabian TC; Echols RM; Jemsek JG; LeFrock JL; Mogabgab WC; Wilson SE
Am J Surg; 1988 May; 155(5A):91-5. PubMed ID: 3287976
[TBL] [Abstract][Full Text] [Related]
10. Results of a randomized, multicenter, comparative trial of a single dose of cefotetan versus multiple doses of cefoxitin as prophylaxis in cesarean section.
McGregor JA; Gordon SF; Krotec J; Poindexter AN
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):701-6. PubMed ID: 3281461
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
Sweet RL; Schachter J; Landers DV; Ohm-Smith M; Robbie MO
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):736-41. PubMed ID: 3162653
[TBL] [Abstract][Full Text] [Related]
12. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ward A; Richards DM
Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy.
Berkeley AS; Freedman KS; Ledger WJ; Orr JW; Benigno BB; Gordon SF; McGregor JA; Galask RP; Sevin BU
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):706-9. PubMed ID: 3128112
[TBL] [Abstract][Full Text] [Related]
14. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery.
Jagelman DG; Fabian TC; Nichols RL; Stone HH; Wilson SE; Zellner SR
Am J Surg; 1988 May; 155(5A):71-6. PubMed ID: 3287972
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of cefotetan in obstetrics and gynecology].
Obata I; Imagawa N; Ochiai K; Koike K; Hachiya S
Jpn J Antibiot; 1983 Sep; 36(9):2461-73. PubMed ID: 6581343
[TBL] [Abstract][Full Text] [Related]
16. Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
Bracero LA
Gynecol Obstet Invest; 1997; 44(1):21-5. PubMed ID: 9251949
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
18. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
Cunningham FG; Hemsell DL; DePalma RT; Kappus S; Roark M; Nobles B
Am J Obstet Gynecol; 1981 Apr; 139(8):915-21. PubMed ID: 6452816
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.
Nolen TM; Phillips HL; Hall HJ
J Antimicrob Chemother; 1983 Jan; 11 Suppl():233-6. PubMed ID: 6573322
[TBL] [Abstract][Full Text] [Related]
20. Moxalactam therapy for obstetric and gynecologic infections.
Gall SA; Addison WA; Hill GB
Rev Infect Dis; 1982; 4 Suppl():S701-7. PubMed ID: 6218587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
